Zhejiang Shengda Bio-Pharm Co., Ltd.SSE: 603079

Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash Management

· Issued by Zhejiang Shengda Bio-Pharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

On 6ix: 6ix.com/news/zhejiang-shengda-bio-pharm-co-ltdannouncement-on-progress-in-opening-dedicated-settlement-account-for-cash-management-products-purchased-with-raised-funds-and-using-idle-raised-funds-for-cash-management

Release

Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash Management

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix

Earlier from Zhejiang Shengda Bio-Pharm

Later from Zhejiang Shengda Bio-Pharm

All Zhejiang Shengda Bio-Pharm news releases